Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency.

Patti G, Noli S, Capalbo D, Allegri AME, Napoli F, Cappa M, Ubertini GM, Gallizia A, Notarnicola S, Ibba A, Crocco M, Parodi S, Salerno M, Loche S, Garré ML, Tornari E, Maghnie M, Di Iorgi N.

Front Endocrinol (Lausanne). 2019 Jul 31;10:525. doi: 10.3389/fendo.2019.00525. eCollection 2019.

2.

Postoperative Opioid Use Before and After Enhanced Recovery After Surgery Program Implementation.

Liu VX, Eaton A, Lee DC, Reyes VM, Paulson SS, Campbell CI, Avins AL, Parodi SM.

Ann Surg. 2019 Jun 20. doi: 10.1097/SLA.0000000000003409. [Epub ahead of print] No abstract available.

PMID:
31232786
3.

Childhood infectious diseases and risk of non-Hodgkin's lymphoma according to the WHO classification: A reanalysis of the Italian multicenter case-control study.

Parodi S, Seniori Costantini A, Crosignani P, Fontana A, Miligi L, Nanni O, Piro S, Ramazzotti V, Rodella S, Tumino R, Vindigni C, Vineis P, Stagnaro E.

Int J Cancer. 2019 May 11. doi: 10.1002/ijc.32393. [Epub ahead of print]

PMID:
31077355
4.

Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.

Parodi S, Pistorio A, Erminio G, Ognibene M, Morini M, Garaventa A, Gigliotti AR, Haupt R, Frassoni F, Pezzolo A.

Pediatr Blood Cancer. 2019 May;66(5):e27635. doi: 10.1002/pbc.27635. Epub 2019 Jan 28.

PMID:
30688024
5.

Differentiating features of posterior fossa at 12-13 weeks' gestation in fetuses with Dandy-Walker malformation and Blake's pouch cyst.

Paladini D, Donarini G, Parodi S, Chaoui R.

Ultrasound Obstet Gynecol. 2019 Jun;53(6):850-852. doi: 10.1002/uog.20190. No abstract available.

PMID:
30575134
6.

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma.

Morandi F, Amoroso L, Dondero A, Castriconi R, Parodi S, Luksch R, Casale F, Castellano A, Garaventa A, Moretta A, Bottino C, Ponzoni M, Corrias MV.

Oncoimmunology. 2018 Jul 30;7(9):e1468953. doi: 10.1080/2162402X.2018.1468953. eCollection 2018.

7.

Hindbrain morphometry and choroid plexus position in differential diagnosis of posterior fossa cystic malformations.

Paladini D, Donarini G, Parodi S, Volpe G, Sglavo G, Fulcheri E.

Ultrasound Obstet Gynecol. 2019 Aug;54(2):207-214. doi: 10.1002/uog.20120.

PMID:
30207001
8.

The third ventricle of the human fetal brain: Normative data and pathologic correlation. A 3D transvaginal neurosonography study.

Birnbaum R, Parodi S, Donarini G, Meccariello G, Fulcheri E, Paladini D.

Prenat Diagn. 2018 Aug;38(9):664-672. doi: 10.1002/pd.5292. Epub 2018 Jun 21.

PMID:
29858521
9.

Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Stagnaro E, Parodi S, Costantini AS, Crosignani P, Miligi L, Nanni O, Piro S, Ramazzotti V, Rodella S, Tumino R, Vindigni C, Vineis P.

Epidemiol Infect. 2018 Sep;146(12):1572-1574. doi: 10.1017/S0950268818001413. Epub 2018 May 30.

PMID:
29843844
10.

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.

Corrias MV, Parodi S, Tchirkov A, Lammens T, Vicha A, Pasqualini C, Träger C, Yáñez Y, Dallorso S, Varesio L, Luksch R, Laureys G, Valteau-Couanet D, Canete A, Pöetschger U, Ladenstein R, Burchill SA.

Pediatr Blood Cancer. 2018 Jul;65(7):e27052. doi: 10.1002/pbc.27052. Epub 2018 Mar 30.

11.

The Kaiser Permanente Northern California Enhanced Recovery After Surgery Program: Design, Development, and Implementation.

Liu VX, Rosas E, Hwang JC, Cain E, Foss-Durant A, Clopp M, Huang M, Mustille A, Reyes VM, Paulson SS, Caughey M, Parodi S.

Perm J. 2017;21:17-003. doi: 10.7812/TPP/17-003.

12.

Coffee consumption and risk of non-Hodgkin's lymphoma: evidence from the Italian multicentre case-control study.

Parodi S, Merlo FD, Stagnaro E; Working Group for the Epidemiology of Hematolymphopoietic Malignancies in Italy.

Cancer Causes Control. 2017 Aug;28(8):867-876. doi: 10.1007/s10552-017-0909-8. Epub 2017 Jun 13.

PMID:
28612129
13.

Enhanced Recovery After Surgery Program Implementation in 2 Surgical Populations in an Integrated Health Care Delivery System.

Liu VX, Rosas E, Hwang J, Cain E, Foss-Durant A, Clopp M, Huang M, Lee DC, Mustille A, Kipnis P, Parodi S.

JAMA Surg. 2017 Jul 19;152(7):e171032. doi: 10.1001/jamasurg.2017.1032. Epub 2017 Jul 19.

14.

Identifying Environmental and Social Factors Predisposing to Pathological Gambling Combining Standard Logistic Regression and Logic Learning Machine.

Parodi S, Dosi C, Zambon A, Ferrari E, Muselli M.

J Gambl Stud. 2017 Dec;33(4):1121-1137. doi: 10.1007/s10899-017-9679-1.

PMID:
28255941
15.

Coffee and tea consumption and risk of leukaemia in an adult population: A reanalysis of the Italian multicentre case-control study.

Parodi S, Merlo DF, Stagnaro E; Working Group for the Epidemiology of Hematolymphopoietic Malignancies in Italy.

Cancer Epidemiol. 2017 Apr;47:81-87. doi: 10.1016/j.canep.2017.01.005. Epub 2017 Jan 30.

PMID:
28153669
16.

Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.

Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, Miranda HC, Lievens PM, Espinoza S, Jochum T, Rocchi A, Grunseich C, Gainetdinov RR, Cato AC, Lieberman AP, La Spada AR, Sambataro F, Fischbeck KH, Gozes I, Pennuto M.

Sci Transl Med. 2016 Dec 21;8(370):370ra181. doi: 10.1126/scitranslmed.aaf9526.

PMID:
28003546
17.

[Documented and suspected risk factors for childhood cancer aetiology].

Magnani C, Miligi L, Parodi S.

Epidemiol Prev. 2016 Sep-Oct;40(5Suppl2):10-16. Italian.

18.

Logic Learning Machine and standard supervised methods for Hodgkin's lymphoma prognosis using gene expression data and clinical variables.

Parodi S, Manneschi C, Verda D, Ferrari E, Muselli M.

Health Informatics J. 2018 Mar;24(1):54-65. doi: 10.1177/1460458216655188. Epub 2016 Jun 27.

PMID:
27354395
19.

Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial.

Castagnino N, Maffei M, Tortolina L, Zoppoli G, Piras D, Nencioni A, Moran E, Ballestrero A, Patrone F, Parodi S.

Wiley Interdiscip Rev Syst Biol Med. 2016 Jul;8(4):314-36. doi: 10.1002/wsbm.1342. Epub 2016 May 30. Review.

20.

Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

Rocchi A, Milioto C, Parodi S, Armirotti A, Borgia D, Pellegrini M, Urciuolo A, Molon S, Morbidoni V, Marabita M, Romanello V, Gatto P, Blaauw B, Bonaldo P, Sambataro F, Robins DM, Lieberman AP, Sorarù G, Vergani L, Sandri M, Pennuto M.

Acta Neuropathol. 2016 Jul;132(1):127-44. doi: 10.1007/s00401-016-1550-4. Epub 2016 Mar 12.

21.

Lifestyle factors and risk of leukemia and non-Hodgkin's lymphoma: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Garrone E, Fontana V, Stagnaro E.

Cancer Causes Control. 2016 Mar;27(3):367-75. doi: 10.1007/s10552-016-0713-x. Epub 2016 Jan 13.

PMID:
26759332
22.

Systems Medicine in Oncology: Signaling Network Modeling and New-Generation Decision-Support Systems.

Parodi S, Riccardi G, Castagnino N, Tortolina L, Maffei M, Zoppoli G, Nencioni A, Ballestrero A, Patrone F.

Methods Mol Biol. 2016;1386:181-219. doi: 10.1007/978-1-4939-3283-2_10. Review.

PMID:
26677185
23.

Differential diagnosis of pleural mesothelioma using Logic Learning Machine.

Parodi S, Filiberti R, Marroni P, Libener R, Ivaldi GP, Mussap M, Ferrari E, Manneschi C, Montani E, Muselli M.

BMC Bioinformatics. 2015;16 Suppl 9:S3. doi: 10.1186/1471-2105-16-S9-S3. Epub 2015 Jun 1.

24.

Chronic diseases, medical history and familial cancer, and risk of leukemia and non-Hodgkin's lymphoma in an adult population: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Sola S, Fontana V, Stagnaro E.

Cancer Causes Control. 2015 Jul;26(7):993-1002. doi: 10.1007/s10552-015-0592-6. Epub 2015 May 16.

PMID:
25982034
25.

Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia.

Rinaldi C, Schmidt T, Situ AJ, Johnson JO, Lee PR, Chen KL, Bott LC, Fadó R, Harmison GH, Parodi S, Grunseich C, Renvoisé B, Biesecker LG, De Michele G, Santorelli FM, Filla A, Stevanin G, Dürr A, Brice A, Casals N, Traynor BJ, Blackstone C, Ulmer TS, Fischbeck KH.

JAMA Neurol. 2015 May;72(5):561-70. doi: 10.1001/jamaneurol.2014.4769. Erratum in: JAMA Neurol. 2015 May;72(5):608.

26.

Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies.

Tortolina L, Duffy DJ, Maffei M, Castagnino N, Carmody AM, Kolch W, Kholodenko BN, De Ambrosi C, Barla A, Biganzoli EM, Nencioni A, Patrone F, Ballestrero A, Zoppoli G, Verri A, Parodi S.

Oncotarget. 2015 Mar 10;6(7):5041-58.

27.

Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy.

Scaramuzzino C, Casci I, Parodi S, Lievens PMJ, Polanco MJ, Milioto C, Chivet M, Monaghan J, Mishra A, Badders N, Aggarwal T, Grunseich C, Sambataro F, Basso M, Fackelmayer FO, Taylor JP, Pandey UB, Pennuto M.

Neuron. 2015 Jan 7;85(1):88-100. doi: 10.1016/j.neuron.2014.12.031.

28.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.

29.

Risk of neuroblastoma, maternal characteristics and perinatal exposures: the SETIL study.

Parodi S, Merlo DF, Ranucci A, Miligi L, Benvenuti A, Rondelli R, Magnani C, Haupt R; SETIL Working Group.

Cancer Epidemiol. 2014 Dec;38(6):686-94. doi: 10.1016/j.canep.2014.09.007. Epub 2014 Oct 1.

PMID:
25280392
30.

Risk of leukaemia and residential exposure to air pollution in an industrial area in Northern Italy: a case-control study.

Parodi S, Santi I, Casella C, Puppo A, Montanaro F, Fontana V, Pescetto M, Stagnaro E.

Int J Environ Health Res. 2015;25(4):393-404. doi: 10.1080/09603123.2014.958136. Epub 2014 Sep 23.

PMID:
25245102
31.

Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.

Cangelosi D, Muselli M, Parodi S, Blengio F, Becherini P, Versteeg R, Conte M, Varesio L.

BMC Bioinformatics. 2014;15 Suppl 5:S4. doi: 10.1186/1471-2105-15-S5-S4. Epub 2014 May 6.

32.

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.

Laroni A, Gandoglia I, Solaro C, Ribizzi G, Tassinari T, Pizzorno M, Parodi S, Baldassarre G, Rilla MT, Venturi S, Capello E, Sormani MP, Uccelli A, Mancardi GL.

BMC Neurol. 2014 May 12;14:103. doi: 10.1186/1471-2377-14-103.

33.

Risk of non-Hodgkin's lymphoma and residential exposure to air pollution in an industrial area in northern Italy: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Vercelli M, Stagnaro E.

Arch Environ Occup Health. 2014;69(3):139-47. doi: 10.1080/19338244.2013.763756.

PMID:
24325744
34.

Seasonal variations of date of diagnosis and birth for neuroblastoma patients in Italy.

Parodi S, Fontana V, Haupt R, Corrias MV.

Cancer Epidemiol. 2013 Oct;37(5):575-8. doi: 10.1016/j.canep.2013.07.003. Epub 2013 Aug 8.

PMID:
23932492
35.

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

Kohler JA, Rubie H, Castel V, Beiske K, Holmes K, Gambini C, Casale F, Munzer C, Erminio G, Parodi S, Navarro S, Marquez C, Peuchmaur M, Cullinane C, Brock P, Valteau-Couanet D, Garaventa A, Haupt R.

Eur J Cancer. 2013 Nov;49(17):3671-9. doi: 10.1016/j.ejca.2013.07.002. Epub 2013 Jul 29.

PMID:
23907002
36.

Causes and risk factors for childhood cancer.

Pisani P, Parodi S, Magnani C.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):234-54. English, Italian. No abstract available.

37.

Childhood infectious diseases and risk of leukaemia in an adult population.

Parodi S, Crosignani P, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Tumino R, Vindigni C, Vineis P, Stagnaro E.

Int J Cancer. 2013 Oct 15;133(8):1892-9. doi: 10.1002/ijc.28205. Epub 2013 Jul 6.

38.

Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA.

Filiberti R, Parodi S, Libener R, Ivaldi GP, Canessa PA, Ugolini D, Bobbio B, Marroni P.

Med Oncol. 2013 Jun;30(2):543. doi: 10.1007/s12032-013-0543-6. Epub 2013 Mar 27.

PMID:
23532816
39.

Parameter space exploration within dynamic simulations of signaling networks.

De Ambrosi C, Barla A, Tortolina L, Castagnino N, Pesenti R, Verri A, Ballestrero A, Patrone F, Parodi S.

Math Biosci Eng. 2013 Feb;10(1):103-20. doi: 10.3934/mbe.2013.10.103.

40.

Infectious diseases and risk of leukemia and non-Hodgkin's lymphoma: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Sola S, Fontana V, Stagnaro E.

Leuk Res. 2012 Nov;36(11):1354-8. doi: 10.1016/j.leukres.2012.08.016. Epub 2012 Aug 31.

PMID:
22940258
41.

Restricted ROC curves are useful tools to evaluate the performance of tumour markers.

Parodi S, Muselli M, Carlini B, Fontana V, Haupt R, Pistoia V, Corrias MV.

Stat Methods Med Res. 2016 Feb;25(1):294-314. doi: 10.1177/0962280212452199. Epub 2012 Jun 26.

PMID:
22735161
42.

Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.

Stec-Martyna E, Ponassi M, Miele M, Parodi S, Felli L, Rosano C.

Curr Cancer Drug Targets. 2012 Jul;12(6):658-66. Review.

PMID:
22385515
43.

Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond.

Ballestrero A, Garuti A, Cirmena G, Rocco I, Palermo C, Nencioni A, Scabini S, Zoppoli G, Parodi S, Patrone F.

Curr Cancer Drug Targets. 2012 May;12(4):316-28. Review.

PMID:
22385512
44.

A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs.

Tortolina L, Castagnino N, De Ambrosi C, Moran E, Patrone F, Ballestrero A, Parodi S.

Curr Cancer Drug Targets. 2012 May;12(4):339-55. Review.

PMID:
22385511
45.

Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.

Bagnasco L, Piras D, Parodi S, Bauer I, Zoppoli G, Patrone F, Ballestrero A.

Curr Cancer Drug Targets. 2012 May;12(4):303-15. Review.

PMID:
22385510
46.

EDITORIAL: Molecularly targeted treatments for colorectal cancer: advances and limitations.

Parodi S.

Curr Cancer Drug Targets. 2012 May;12(4):301-2. No abstract available.

PMID:
22385508
47.

Cyto-morphologic evaluation of bone marrow in infants with disseminated neuroblastoma.

Sorrentino S, Rosanda C, Parodi S, Rita Gigliotti A, Pasino M, Defferrari R, Tonini GP, De Bernardi B.

J Pediatr Hematol Oncol. 2012 Mar;34(2):154-8. doi: 10.1097/MPH.0b013e31821d80be.

PMID:
22367387
48.

The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B.

Parodi S, Di Zanni E, Di Lascio S, Bocca P, Prigione I, Fornasari D, Pennuto M, Bachetti T, Ceccherini I.

J Mol Med (Berl). 2012 Sep;90(9):1025-35. doi: 10.1007/s00109-012-0868-1. Epub 2012 Feb 4.

PMID:
22307522
49.

Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.

Scaruffi P, Morandi F, Gallo F, Stigliani S, Parodi S, Moretti S, Bonassi S, Fardin P, Garaventa A, Zanazzo G, Pistoia V, Tonini GP, Corrias MV.

Pediatr Blood Cancer. 2012 Jul 15;59(1):44-51. doi: 10.1002/pbc.23339. Epub 2011 Oct 12.

PMID:
21994039
50.

In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins.

Di Zanni E, Bachetti T, Parodi S, Bocca P, Prigione I, Di Lascio S, Fornasari D, Ravazzolo R, Ceccherini I.

Neurobiol Dis. 2012 Jan;45(1):508-18. doi: 10.1016/j.nbd.2011.09.007. Epub 2011 Sep 21.

PMID:
21964250

Supplemental Content

Loading ...
Support Center